A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants

NCT07737717 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Ebola-Bundibugyo Virus Disease (Ebola-BDBV)

Interventions

BIOLOGICAL: mRNA-1469
BIOLOGICAL: Placebo

Sponsor

ModernaTX, Inc.